Metabolic or pseudometabolic syndrome?
Luis Cláudio Lemos Correia1, Adriana L Latado, José Augusto Barreto-Filho
1Escola Bahiana de Medicina, Salvador/BA, Brazil. lccorreia@cardiol.br
Arquivos Brasileiros De Cardiologia
|June 28, 2012
Summary
Metabolic syndrome is often suggested to predict cardiovascular risk, but scientific evidence is weak. This review challenges the established view on metabolic syndrome
Area of Science:
- Cardiology
- Metabolic Disorders
Background:
- Metabolic syndrome is frequently cited as a key indicator of cardiovascular risk.
- However, the scientific foundation supporting this claim is often debated.
- Existing paradigms regarding its prognostic value require critical evaluation.
Purpose of the Study:
- To critically review the scientific evidence linking metabolic syndrome to cardiovascular risk.
- To challenge the prevailing notion of metabolic syndrome as a reliable predictor of cardiovascular events.
- To re-evaluate the prognostic significance of metabolic syndrome in clinical practice.
Main Methods:
- Systematic literature review of studies investigating metabolic syndrome and cardiovascular outcomes.
- Critical appraisal of epidemiological data and clinical trial evidence.
- Analysis of the pathophysiological links between metabolic syndrome components and atherosclerosis.
Main Results:
- The evidence directly linking metabolic syndrome as an independent predictor of cardiovascular risk is limited and often confounded.
- Many studies fail to demonstrate added prognostic value beyond individual risk factors.
- The diagnostic criteria for metabolic syndrome may lack specificity and clinical utility.
Conclusions:
- The current scientific basis for metabolic syndrome as a strong predictor of cardiovascular risk is insufficient.
- Challenging the established paradigm is necessary for accurate risk assessment.
- Further research is needed to clarify the precise role of metabolic syndrome in cardiovascular disease.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:19Overview of Carbohydrate Metabolism
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...